“Assessment Of The Anti-angiogenic Effect Of Imatinib And Epigallocatechin-3-Gallate On Laryngeal Carcinoma Cell Line (Hep2)” In Vitro Study
Basma Abdelrahman Ahmed;
Abstract
The aim of the present study was to evaluate the antiangiogenic effect of
Imatinib and Epigallocatechin-3-gallate, used separately or in
combination, on VEGF expression in Hep2 cell line.
The IC50 dose was calculated for imatinib and EGCG on Hep-2 cell line.
The doses used in the study were the IC50 dose, one higher dose for each
drug and two combination doses.
Imatinib and Epigallocatechin-3-gallate, used separately or in
combination, on VEGF expression in Hep2 cell line.
The IC50 dose was calculated for imatinib and EGCG on Hep-2 cell line.
The doses used in the study were the IC50 dose, one higher dose for each
drug and two combination doses.
Other data
| Title | “Assessment Of The Anti-angiogenic Effect Of Imatinib And Epigallocatechin-3-Gallate On Laryngeal Carcinoma Cell Line (Hep2)” In Vitro Study | Other Titles | " تقييم التأثير المضاد لتكوين الأوعية الدموية للإيما تينيب و الإبيجالوكتشين3 جالات على خط خلايا سرطان الحنجرة (ه ى ب 2(" دراسة معملية | Authors | Basma Abdelrahman Ahmed | Issue Date | 2019 |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| CC2171.pdf | 577.59 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.